Clinical Trial Update: Role of Magnesium Supplementation in the Treatment of Depression [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports completed results for magnesium supplementation in treatment of depression across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Magnesium supplementation (magnesium)

Snippet

Sponsor: University of Vermont | Conditions: Depression | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-05-08